Pfizer to Raise R&D Spending as Pipeline Focus Sharpens

Pfizer Inc. plans to increase research and development spending for the remainder of the year in a bid to accelerate the delivery of potential blockbuster treatments to market.

The drugmaker on Tuesday raised projections for spending on research to $7.7 billion to $8.1 billion from $7.4 billion and $7.9 billion previously.

Pfizer affirmed…

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *